Sierra Oncology Inc. (SRRA) Fundamentals

Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization of DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer in the United States and internationally. The company's lead drug candidate is SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, which is in Phase 1 clinical trial to treat patients with advanced cancer. In addition, it also engaged in developing SRA141, an orally bioavailable small molecule inhibitor of the cell division cycle 7 kinase that is in the preclinical development stage.
SHARE INFORMATION
Market Cap$ 1,251,257,857
Shares Outstanding24,419,349
Float14,647,536
Percent Float64.37%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -7.12
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions146
Institutional Holdings Date2022-06-30
Institutional Bought Previous 3 Months4,135,079
Institutional Holdings Percent78.6%
Institutional Sold Previous 3 Months2,072,860
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months381,106
Insider Holdings Percent2.1
Insider Sold Previous 3 Months5,553
Insider Shares Owned501,315
TRADING INFO
52 Week High$ 55.19
52 Week Low$ 14.91
52 Week High Change$ 184.48
21 Day Moving Average$ 54.99
21 Day Extended Moving Average$ 54.988
50 Day Moving Average$ 54.99
50 Day Extended Moving Average$ 54.6011
200 Day Moving Average$ 41.6935
200 Day Extended Moving Average$ 44.3446
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume17,256
Alpha0.017183
Beta0.0073
Standard Deviation0.203482
R20.000003
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price Change$ 25.69
180 Day Percent Change87.68%
200 Day Price Change$ 23.28
200 Day Percent Change73.42%
Year to Date Price Change$ 33.25
Year to Date Percent Change152.94%

Sierra Oncology Inc. (SRRA) Key Ratios

PROFITABILITY
EBIT Margin-43,453.5%
EBITDA Margin-43,323.5%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book5.10
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio21.30
Leverage Ratio1.10
Quick Ratio21.00
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-8.20
Enterprise Value$ 1,074,421,001
Price to Sales0.00
Price to Free Cash-19.00
PE High Last 5 Years-0.60
Price To Book5.10
Price To Cash Flow0.00
PE Low Last 5 Years-1.80
Price to Tangible Book5.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-53.42
Return on Equity-57.44
Return on Capital-55.63

Sierra Oncology Inc. (SRRA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEO-
Emplyoees109
Last AuditUQ
CIK0001290149
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1820 Gateway Drive
Suite 110
San Mateo, CA 94404
Websitehttps://www.sierraoncology.com
Facsimile-
Telephone+1 650 376-8679
Emailinvestors@sierraoncology.com


Your Recent History
NASDAQ
SRRA
Sierra Onc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.